Michael Cherny
Stock Analyst at Leerink Partners
(3.11)
# 1,198
Out of 4,412 analysts
65
Total ratings
45.21%
Success rate
0.27%
Average return
Main Sectors:
27 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BOLD Boundless Bio | Initiates: Outperform | $25 | $11.64 | +114.78% | 1 | Apr 22, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Market Perform | $23 → $22 | $17.70 | +24.29% | 2 | Mar 18, 2024 | |
| DGX Quest Diagnostics | Initiates: Market Perform | $135 | $134.26 | +0.55% | 1 | Feb 26, 2024 | |
| PGNY Progyny | Initiates: Outperform | $49 | $32.04 | +52.93% | 3 | Feb 26, 2024 | |
| IQV IQVIA Holdings | Initiates: Outperform | $290 | $234.88 | +23.47% | 1 | Feb 26, 2024 | |
| CAH Cardinal Health | Initiates: Outperform | $125 | $103.21 | +21.11% | 4 | Feb 26, 2024 | |
| COR Cencora | Initiates: Outperform | $261 | $240.88 | +8.35% | 1 | Feb 26, 2024 | |
| LH Laboratory Corporation of America Holdings | Initiates: Outperform | $260 | $198.40 | +31.05% | 1 | Feb 26, 2024 | |
| PINC Premier | Initiates: Market Perform | $23 | $20.96 | +7.35% | 3 | Feb 26, 2024 | |
| MCK McKesson | Initiates: Outperform | $600 | $543.30 | +10.44% | 3 | Feb 26, 2024 | |
| HIMS Hims & Hers Health | Initiates: Market Perform | $10 | $12.50 | -20.00% | 4 | Feb 26, 2024 | |
| GDRX GoodRx Holdings | Initiates: Outperform | $8 | $7.19 | +11.27% | 4 | Feb 26, 2024 | |
| DOCS Doximity | Initiates: Market Perform | $32 | $23.82 | +34.34% | 1 | Feb 26, 2024 | |
| CERT Certara | Initiates: Market Perform | $19 | $16.57 | +14.67% | 1 | Feb 26, 2024 | |
| RCM R1 RCM | Initiates: Outperform | $14 | $11.90 | +17.65% | 3 | Feb 26, 2024 | |
| NVST Envista Holdings | Initiates: Underperform | $19 | $20.39 | -6.82% | 4 | Feb 26, 2024 | |
| XRAY DENTSPLY SIRONA | Initiates: Outperform | $42 | $30.57 | +37.39% | 3 | Feb 26, 2024 | |
| PDCO Patterson Companies | Initiates: Outperform | $36 | $25.77 | +39.70% | 5 | Feb 26, 2024 | |
| ALGN Align Technology | Initiates: Market Perform | $310 | $309.02 | +0.32% | 1 | Feb 26, 2024 | |
| HSIC Henry Schein | Initiates: Market Perform | $78 | $73.13 | +6.66% | 1 | Feb 26, 2024 | |
| ACCD Accolade | Initiates: Outperform | $16 | $7.89 | +102.79% | 6 | Feb 26, 2024 | |
| CVS CVS Health | Initiates: Outperform | $88 | $67.18 | +30.99% | 5 | Feb 26, 2024 | |
| TDOC Teladoc Health | Initiates: Market Perform | $17 | $13.01 | +30.67% | 1 | Feb 26, 2024 | |
| AKLI Akili | Initiates: Neutral | $2 | $0.25 | +716.33% | 1 | Nov 18, 2022 | |
| GOCO GoHealth | Downgrades: Underperform | $113 → $53 | $10.15 | +417.24% | 2 | Jan 5, 2022 | |
| SONX Sonendo | Initiates: Buy | n/a | $0.09 | - | 1 | Nov 23, 2021 | |
| MDRX Veradigm | Maintains: Buy | n/a | $7.96 | - | 2 | Nov 2, 2018 |
Boundless Bio
Apr 22, 2024
Initiates: Outperform
Price Target: $25
Current: $11.64
Upside: +114.78%
Walgreens Boots Alliance
Mar 18, 2024
Maintains: Market Perform
Price Target: $23 → $22
Current: $17.70
Upside: +24.29%
Quest Diagnostics
Feb 26, 2024
Initiates: Market Perform
Price Target: $135
Current: $134.26
Upside: +0.55%
Progyny
Feb 26, 2024
Initiates: Outperform
Price Target: $49
Current: $32.04
Upside: +52.93%
IQVIA Holdings
Feb 26, 2024
Initiates: Outperform
Price Target: $290
Current: $234.88
Upside: +23.47%
Cardinal Health
Feb 26, 2024
Initiates: Outperform
Price Target: $125
Current: $103.21
Upside: +21.11%
Cencora
Feb 26, 2024
Initiates: Outperform
Price Target: $261
Current: $240.88
Upside: +8.35%
Laboratory Corporation of America Holdings
Feb 26, 2024
Initiates: Outperform
Price Target: $260
Current: $198.40
Upside: +31.05%
Premier
Feb 26, 2024
Initiates: Market Perform
Price Target: $23
Current: $20.96
Upside: +7.35%
McKesson
Feb 26, 2024
Initiates: Outperform
Price Target: $600
Current: $543.30
Upside: +10.44%
Hims & Hers Health
Feb 26, 2024
Initiates: Market Perform
Price Target: $10
Current: $12.50
Upside: -20.00%
GoodRx Holdings
Feb 26, 2024
Initiates: Outperform
Price Target: $8
Current: $7.19
Upside: +11.27%
Doximity
Feb 26, 2024
Initiates: Market Perform
Price Target: $32
Current: $23.82
Upside: +34.34%
Certara
Feb 26, 2024
Initiates: Market Perform
Price Target: $19
Current: $16.57
Upside: +14.67%
R1 RCM
Feb 26, 2024
Initiates: Outperform
Price Target: $14
Current: $11.90
Upside: +17.65%
Envista Holdings
Feb 26, 2024
Initiates: Underperform
Price Target: $19
Current: $20.39
Upside: -6.82%
DENTSPLY SIRONA
Feb 26, 2024
Initiates: Outperform
Price Target: $42
Current: $30.57
Upside: +37.39%
Patterson Companies
Feb 26, 2024
Initiates: Outperform
Price Target: $36
Current: $25.77
Upside: +39.70%
Align Technology
Feb 26, 2024
Initiates: Market Perform
Price Target: $310
Current: $309.02
Upside: +0.32%
Henry Schein
Feb 26, 2024
Initiates: Market Perform
Price Target: $78
Current: $73.13
Upside: +6.66%
Accolade
Feb 26, 2024
Initiates: Outperform
Price Target: $16
Current: $7.89
Upside: +102.79%
CVS Health
Feb 26, 2024
Initiates: Outperform
Price Target: $88
Current: $67.18
Upside: +30.99%
Teladoc Health
Feb 26, 2024
Initiates: Market Perform
Price Target: $17
Current: $13.01
Upside: +30.67%
Akili
Nov 18, 2022
Initiates: Neutral
Price Target: $2
Current: $0.25
Upside: +716.33%
GoHealth
Jan 5, 2022
Downgrades: Underperform
Price Target: $113 → $53
Current: $10.15
Upside: +417.24%
Sonendo
Nov 23, 2021
Initiates: Buy
Price Target: n/a
Current: $0.09
Upside: -
Veradigm
Nov 2, 2018
Maintains: Buy
Price Target: n/a
Current: $7.96
Upside: -